Ticker
APYXCompany Name
APYX MEDICAL CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 58.19M | $ 29.3M | 50.36% |
3/31/2025 | $ 60.16M | $ 31.01M | 51.55% |
12/31/2024 | $ 64.84M | $ 31.74M | 48.95% |
9/30/2024 | $ 60.72M | $ 28.01M | 46.13% |
6/30/2024 | $ 65.39M | $ 32.68M | 49.97% |
3/31/2024 | $ 70.71M | $ 37.28M | 52.72% |
12/31/2023 | $ 79.24M | $ 43.65M | 55.09% |
9/30/2023 | $ 59.45M | $ 22.13M | 37.23% |
6/30/2023 | $ 62.43M | $ 18.48M | 29.6% |
3/31/2023 | $ 56.78M | $ 16.25M | 28.63% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for APYX MEDICAL CORP is calculated as follows: CashnEq [ $ 43.54M ] / Assets [ $ 75.42M ]
(=) Cash to Assets [ 57.73% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.8% |
average | 9.79% |
median | 6.44% |
std | 9.55% |